| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Nov 18, 2025 | GENMAB | Genmab A/S | Ba2 | BB+ | BB+ | $1,500 | Sr. Secured | 7.00 | 3.00 | Dec-32 | 6.25% | HYC | EMEA | ||||
HLTH | PRCD | Nov 18, 2025 | GENMAB | Genmab A/S | B1 | BB- | BB | $1,000 | Sr. Unsecured | 8.00 | 3.00 | Dec-33 | 7.25% | HYC | EMEA | ||||
HLTH | PRCD | Nov 12, 2024 | SOBIV | Swedish Orphan Biovitrum AB (publ) | - | - | - | kr1,150 | Sr. Unsecured | 2.00 | - | Nov-26 | 3mSt+90 | HYC | EMEA | ||||
HLTH | PRCD | Nov 12, 2024 | SOBIV | Swedish Orphan Biovitrum AB (publ) | - | - | - | kr1,350 | Sr. Unsecured | 5.25 | - | Feb-30 | 3mS+160 | HYC | EMEA | ||||
HLTH | PRCD | Sep 28, 2021 | GRFSM | Grifols SA | B3 | B | B+ | €1,400 | Sr. Unsecured | 7.00 | 3.00 | Oct-28 | 3.875% | HYC | EMEA | ||||
HLTH | PRCD | Sep 28, 2021 | GRFSM | Grifols SA | B3 | B | B+ | $705 | Sr. Unsecured | 7.00 | 3.00 | - | 4.750% | HYC | EMEA | ||||
HLTH | PRCD | Jun 16, 2021 | HBMN | HBM Healthcare Investments AG | NR | NR | - | CHF100 | Sr. Unsecured | 6.00 | - | Jul-27 | 1.125% | HYC | EMEA | ||||
HLTH | PRCD | Nov 8, 2019 | GRFSM | Grifols SA | Ba2 | BB+ | - | €905 | Sr. Secured | 5.25 | - | Feb-25 | 1.625% | HYC | EMEA | ||||
HLTH | PRCD | Nov 8, 2019 | GRFSM | Grifols SA | Ba2 | BB+ | - | €770 | Sr. Secured | 8.00 | - | Nov-27 | 2.25% | HYC | EMEA |